QQ客服 官方微博 反馈留言

	Erianin inhibits human cervical cancer cell through regulation of tumor protein p53 via the extracellular signal-regulated kinase signaling pathway
	Li, Mengting[1,2]; He, Yulin[1,2]; Peng, Cheng[1,2]; Xie, Xiaofang[1,2]; Hu, Guanying[1,2]
	2018
卷号	16期号:4页码:5006-5012
URL标识	查看原文
WOS记录号	WOS:000444990700117
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4328247
专题	成都中医药大学
作者单位	1.[1]Chengdu Univ Tradit Chinese Med, State Key Lab Breeding Base Systemat Res Dev & Ut, Chengdu 611137, Sichuan, Peoples R China 2.[2]Chengdu Univ Tradit Chinese Med, Sch Pharm, 1166 Liutai Rd, Chengdu 611137, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Li, Mengting[1,2],He, Yulin[1,2],Peng, Cheng[1,2],et al. Erianin inhibits human cervical cancer cell through regulation of tumor protein p53 via the extracellular signal-regulated kinase signaling pathway[J],2018,16(4):5006-5012.
APA	Li, Mengting[1,2],He, Yulin[1,2],Peng, Cheng[1,2],Xie, Xiaofang[1,2],&Hu, Guanying[1,2].(2018).Erianin inhibits human cervical cancer cell through regulation of tumor protein p53 via the extracellular signal-regulated kinase signaling pathway.,16(4),5006-5012.
MLA	Li, Mengting[1,2],et al."Erianin inhibits human cervical cancer cell through regulation of tumor protein p53 via the extracellular signal-regulated kinase signaling pathway".16.4(2018):5006-5012.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。